MTOR as a target for therapy of renal cancer
Hudes, G.R.
Clinical Advances in Hematology and Oncology H&o 5(10): 772-774
2007
ISSN/ISBN: 1543-0790 PMID: 17998894 Document Number: 611424
Document emailed within 1 workday
Related Documents
Nakagawa, Y.; Ikeda, M.; Tasaki, M.; Saito, K.; Takahashi, K. 2013: The new immunosuppressive drugs for renal transplantation: inhibitors of the mammalian target of rapamycin (mTOR) and anti-thymocyte globulin (Thymoglobulin) Nihon Jinzo Gakkai Shi 55(2): 112-118Benderli Cihan, Y. 2018: Role of mTOR signaling pathway proteins and proteins influencing mTOR pathway in resistance to radiotherapy in prostate cancer Journal of Buon: Official Journal of the Balkan Union of Oncology 23(6): 1931-1932
Gerullis, H.; Ecke, T.H.; Eimer, C.; Heuck, C.J.; Otto, T. 2010: MTOR-inhibition in metastatic renal cell carcinoma. Focus on temsirolimus: a review Minerva Urologica e Nefrologica 62(4): 411-423
Rachdi, H.; Mokrani, A.; Batti, R.; Ayadi, M.; Chraiet, N.; Mezlini, A. 2018: Target therapy for metastatic breast cancer La Tunisie Medicale 96(8-9): 465-471
Lin, F.; Zhang, P.L.; Yang, X.J.; Prichard, J.W.; Lun, M.; Brown, R.E. 2006: Morphoproteomic and molecular concomitants of an overexpressed and activated mTOR pathway in renal cell carcinomas Annals of Clinical and Laboratory Science 36(3): 283-293
Gali-Muhtasib, H.U.; Diab-Assef, M.; Haddadin, M.J. 2002: Hypoxic cells in tumors as a target for cancer therapy Le Journal Medical Libanais. Lebanese Medical Journal 50(4): 175-179
Pasetto, L.Maria.; Bortolami, A.; Falci, C.; Sinigaglia, G.; Monfardini, S. 2006: Recent progress in target therapy in colorectal cancer Anticancer Research 26(5b): 3973-3981
Ochiai, A. 2011: Standardization of evaluation for target molecule in cancer therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(5): 709-714
Bifulco, M.; Di Marzo, V. 2003: The endocannabinoid system as a target for the development of new drugs for cancer therapy Recenti Progressi in Medicina 94(5): 194-198
Hirao, A. 2015: Regulation of cancer behavior mediated by mTOR signal Nihon Rinsho. Japanese Journal of Clinical Medicine 73(5): 773-778
Maiese, K. 2013: Therapeutic targets for cancer: current concepts with Pi 3-K, Akt, and mTOR Indian Journal of Medical Research 137(2): 243-246
Avantaggiati, M.L. 2013: Cancer metabolism as a therapeutic target: finding the right target(s) in the context of tumor heterogeneity, evolution, and metabolic plasticity Oncology 27(5): 474; 476-477
Tamura, T. 2002: Molecular target-based cancer therapy: epidermal growth factor receptor inhibitors Nihon Geka Gakkai Zasshi 103(2): 233-236
Sugiyama, M.; Takahashi, H.; Hosono, K.; Endo, H.; Kato, S.; Yoneda, K.; Nozaki, Y.; Fujita, K.; Yoneda, M.; Wada, K.; Nakagama, H.; Nakajima, A. 2009: Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway International Journal of Oncology 34(2): 339-344
Liu, Y.; Zhang, X.; Liu, P.; Zhang, J. 2015: Drug sensitivity research of mTOR inhibitor on breast cancer stem cells Zhonghua Yi Xue Za Zhi 95(24): 1910-1914
Zhang, C.-z.; Wang, X.-d.; Wang, H.-w.; Cai, Y.; Chao, L.-q. 2015: Sorafenib inhibits liver cancer growth by decreasing mTOR, AKT, and PI3K expression Journal of Buon: Official Journal of the Balkan Union of Oncology 20(1): 218-222
Ma, Q.; Chang, Z.; Wang, W.; Wang, B. 2015: Rapamycin-Mediated mTOR Inhibition Reverses Drug Resistance to Adriamycin in Colon Cancer Cells Hepato-Gastroenterology 62(140): 880-886
Liu, K.J.; Chatta, G.S.; Twardzik, D.R.; Vedvick, T.S.; True, L.D.; Spies, A.G.; Cheever, M.A. 1997: Identification of rat prostatic steroid-binding protein as a target antigen of experimental autoimmune prostatitis: implications for prostate cancer therapy Journal of Immunology 159(1): 472-480
Igarashi, T.; Nagata, O.; Iwakiri, H.; Ikeda, M.; Ozaki, M. 2009: Evaluation of target-controlled infusion for propofol in patients with chronic renal failure undergoing living-related renal transplantation Masui. Japanese Journal of Anesthesiology 58(9): 1143-1148
Neidhart, J.A.; Gagen, M.M.; Young, D.; Tuttle, R.; Melink, T.J.; Ziccarrelli, A.; Kisner, D. 1984: Interferon-alpha therapy of renal cancer Cancer Research 44(9): 4140-4143